tm
Seeing Is Believing
tm
Seeing Is Believing
KTRA is currently covered by 1 analysts with an average price target of $120.48. This is a potential upside of $114.18 (1812.38%) from yesterday's end of day stock price of $6.3.
Kintara Therapeutics's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of KTRA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 76 days.
Highest price target for KTRA is $162, Lowest price target is $162.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 14-Jul-2023. First documented stock forecast 06-Sep-2019.
Currently out of the existing stock ratings of KTRA, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$14
$7.7 (122.22%)
2 years 2 days ago
(14-Jul-2023)
2/3 (66.67%)
$9.36 (201.72%)
152
Buy
$300
$295.96 (7325.74%)
4 years 10 months 2 days ago
(14-Sep-2020)
0/1 (0%)
$219 (270.37%)
What is KTRA (Kintara Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KTRA (Kintara Therapeutics) with a proven track record?
Which analyst has the current lower performing score on KTRA (Kintara Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KTRA (Kintara Therapeutics)?
Which analyst is the currently most bullish on KTRA (Kintara Therapeutics)?
Which analyst is the currently most reserved on KTRA (Kintara Therapeutics)?
